返回 Agendas
Welcome to Day 2 and Track Report Outs
Session Chair(s)
Robert T. Dorsam, PHD
Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER
FDA, United States
Welcome to Day 2 and Track Report Outs
Speaker(s)
Welcome Remarks
Robert T. Dorsam, PHD
FDA, United States
Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER
CMC Track Report Out
Kate Arnot, MSC
AstraZeneca, United Kingdom
Regulatory CMC Director
Non Clinical Track Report Out
Imran Khan, PHD
FDA, United States
Pharmacologist, OMPT, OND, ODEI, DPP, CDER
Clinical Track Report Out
Speaker Invited
United States